Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 2, 1996, Pages 274-282

  Foresi, Antonio ^a   Pelucchi, Andrea ^a   Gherson, Gemma ^b   Mastropasqua, Berardino ^a   Chiapparino, Anita ^a   Testi, Renato ^c  

^a Modulo di Allergologia ed Immunopatologia Polmonare   (Italy)

^b Arco di Trento   (Italy)

^c GSK   (Italy)

Author keywords

Allergic rhinitis; Bronchial responsiveness; Fluticasone propionate; Nasal lavage

Indexed keywords

FLUTICASONE PROPIONATE; METHACHOLINE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; HUMAN; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; ITALY; NOSE OBSTRUCTION; PALLIATIVE THERAPY; POLLEN ALLERGY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SEASON;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; FEMALE; HUMANS; HYDROCORTISONE; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; NASAL LAVAGE FLUID; POLLEN; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES; SEASONS;

EID: 0029792736     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70150-1     Document Type: Article

References (32)

1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
2. Pipkorn U, Karlsson G, Enerback L. The cellular response to human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 1988;82:1046-54.
3. Townley RG, Ryo UK, Kolotzin MB, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975;56:429-42.
4. Sotomayor H, Badier M, Vervoloet D, Orehek J. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis 1984;130:56-8.
5. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6.
6. Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernadez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol 1995;95:512-23.
7. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-91.
8. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(suppl A):25-9.
9. Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991;67:332-8.
10. Ratner PH, Paull BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1992;90:285-91.
11. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993;48:327-33.
12. Dockhorn RJ, Pauli BD, Meltzer E, et al. Once- versus twice-daily fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis. Am J Rhinol 1993;7:77-83.
13. Grossman J, Banov C, Bronsky EA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993;92:594-9.
14. Dolovich J, O'Connor M, Stepner N, Smith A, Sharma RK. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed. Ann Allergy 1994;72:435-40.
15. Otsuka H, Denburg JA, Befus AD, et al. Effect of beclomethasone dipropionate on nasal metachromatic cell sub-population. Clin Allergy 1986;16:589-95.
16. Orgel HA, Meltzer E, Kemp JP, Welch MJ. Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol 1986;77:858-64.
17. Karlsson G, Svensson C, Anderson M, Venge P, Pipkorn U, Persson CG. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-10.
18. Meltzer EO, Orgel HA, Bronsky EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990;86:221-30.
19. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
20. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
21. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43:760-75.
22. van Bavel J, Findlay SR, Hampel FC Jr, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-704.
23. Dolovich J, Anderson M, Chodirker W, et al. Fluticasone propionate: a large multicentre trial. Respir Med 1990;84(suppl A):31-2.
24. van As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate. J Allergy Clin Immunol 1993;91:1146-54.
25. Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy 1989;44:342-8.
26. Thomas KE, Greenwood L, Murrant N, Cook J. Devalia JL, Davies RJ. The effects of topical fluticasone propionate on allergen-induced immediate nasal airways response and eosinophil activation: preliminary results. Respir Med 1990;84 (suppl A):33-5.
27. Scadding GK. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge. Br J Clin Pharmacol 1994;38:447-51.
28. Masuyama K, Jacobson MR, Rak S, et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:192-9.
29. Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-888.
30. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611-8.
31. Wood RA, Eggleston PA. The effect of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995;151:315-20.
32. Brauman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987;91:671-4.